Regulation And Legal
ADARx Pharmaceuticals Files Form 4 Sep 29
ADARx Pharmaceuticals submitted a Form 4 filing dated 29 September 2026, as reported on Reuters.
The Reuters article provides only the filing header without transaction details, share quantities, or i
